Position in MRK
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$145,370,250
-$1,096,175 QoQ
Shares Held
1,131,286
-7.1% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#170
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KBC Group NV holds $2,157,048,254 across 10 Drug Manufacturers - General names. MRK ranks #7 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
544,998 | $653,687,004 | |
| 2 | JNJ |
Johnson & Johnson
|
1,322,168 | $335,791,005 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
4,264,357 | $245,712,249 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,644,035 | $207,707,380 | |
| 5 | PFE |
Pfizer Inc
|
8,327,265 | $200,520,541 | |
| 6 | ABBV |
AbbVie Inc.
|
672,932 | $169,336,607 | |
| 7 | MRK |
Merck & Co., Inc.
This page
|
1,131,286 | $145,370,250 | |
| 8 | AMGN |
Amgen Inc
|
382,676 | $138,574,632 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $145,370,250 | 1,131,286 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $146,466,425 | 1,217,611 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $134,536,067 | 1,278,131 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $98,242,497 | 1,170,529 | Shares | Defined | 2026-01-20 | |
| 2025-06-30 | $196,306,270 | 2,479,867 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $214,439,602 | 2,389,033 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $260,265,742 | 2,616,262 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $281,839,907 | 2,481,859 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $416,724,046 | 3,366,107 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $315,024,290 | 2,387,452 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $261,225,764 | 2,396,127 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $226,450,776 | 2,199,619 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $206,236,431 | 1,787,299 | Shares | Defined | 2024-02-15 | |
| 2023-03-31 | $199,089,095 | 1,871,314 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $265,407,265 | 2,392,134 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $168,150,073 | 1,952,509 | Shares | Defined | 2024-02-15 | |
| 2022-06-30 | $181,268,204 | 1,988,244 | Shares | Defined | 2024-02-14 | |
| 2022-03-31 | $62,171,171 | 757,723 | Shares | Defined | 2024-02-14 | |
| 2021-12-31 | $125,809,004 | 1,641,558 | Shares | Defined | 2024-02-14 | |
| 2021-09-30 | $103,547,696 | 1,378,614 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $205,680,029 | 2,644,722 | Shares | Defined | 2022-02-15 | |
| 2021-03-31 | $190,493,500 | 2,471,052 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $222,820,890 | 2,723,973 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $196,087,917 | 2,363,928 | Shares | Defined | 2022-02-14 | |
| 2020-06-30 | $190,231,339 | 2,459,993 | Shares | Defined | 2022-02-14 | |
| 2020-03-31 | $193,377,913 | 2,513,361 | Shares | Defined | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||